IL155657A0 - Acylaminoalkyl-substituted benzenesulfonamide derivatives - Google Patents

Acylaminoalkyl-substituted benzenesulfonamide derivatives

Info

Publication number
IL155657A0
IL155657A0 IL15565701A IL15565701A IL155657A0 IL 155657 A0 IL155657 A0 IL 155657A0 IL 15565701 A IL15565701 A IL 15565701A IL 15565701 A IL15565701 A IL 15565701A IL 155657 A0 IL155657 A0 IL 155657A0
Authority
IL
Israel
Prior art keywords
cardiac
acylaminoalkyl
compounds
heart
formula
Prior art date
Application number
IL15565701A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL155657A0 publication Critical patent/IL155657A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52Y being a hetero atom
    • C07C311/54Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42Sulfonylthioureas; Sulfonylisothioureas
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Hybrid Cells (AREA)
IL15565701A 2000-11-03 2001-10-20 Acylaminoalkyl-substituted benzenesulfonamide derivatives IL155657A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054481A DE10054481A1 (de) 2000-11-03 2000-11-03 Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
PCT/EP2001/012143 WO2002036556A2 (fr) 2000-11-03 2001-10-20 Derives de benzenesulfonamide substitues par acylaminoalkyle, leur preparation, leur utilisation et preparations pharmaceutiques les contenant.

Publications (1)

Publication Number Publication Date
IL155657A0 true IL155657A0 (en) 2003-11-23

Family

ID=7662009

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15565701A IL155657A0 (en) 2000-11-03 2001-10-20 Acylaminoalkyl-substituted benzenesulfonamide derivatives
IL155657A IL155657A (en) 2000-11-03 2003-04-29 Acylaminoalkyl-substituted benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions comprising them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155657A IL155657A (en) 2000-11-03 2003-04-29 Acylaminoalkyl-substituted benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions comprising them

Country Status (12)

Country Link
US (1) US6511989B2 (fr)
EP (1) EP1345892B1 (fr)
JP (1) JP4039625B2 (fr)
AT (1) ATE290525T1 (fr)
AU (2) AU1825302A (fr)
CA (1) CA2427429C (fr)
DE (2) DE10054481A1 (fr)
ES (1) ES2237614T3 (fr)
IL (2) IL155657A0 (fr)
MX (1) MXPA03003608A (fr)
PT (1) PT1345892E (fr)
WO (1) WO2002036556A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6677364B2 (en) * 1998-04-20 2004-01-13 G.D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
EP2438913B1 (fr) * 2002-03-20 2020-05-06 University of Maryland, Baltimore Canal de cations non sélectif dans les cellules neuronales et procédés de traitement du gonflement cérébral
US8980952B2 (en) * 2002-03-20 2015-03-17 University Of Maryland, Baltimore Methods for treating brain swelling with a compound that blocks a non-selective cation channel
AU2003291255A1 (en) * 2002-11-06 2004-06-03 Smithkline Beecham Corporation Sulfonamides
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
GB0412986D0 (en) 2004-06-10 2004-07-14 Xention Discovery Ltd Compounds
EP1802313B1 (fr) * 2004-09-18 2010-11-03 University of Maryland, Baltimore Agents therapeutiques ciblant le canal ncca-atp et leurs methodes d'utilisation
JP5085326B2 (ja) * 2004-09-18 2012-11-28 ユニバーシティ オブ メリーランド,ボルチモア NCCa−ATPチャネルを標的とする処置剤およびその使用方法
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
US9511075B2 (en) * 2007-01-12 2016-12-06 The University Of Maryland, Baltimore Targeting NCCA-ATP channel for organ protection following ischemic episode
EP2114160B1 (fr) * 2007-02-09 2016-11-16 University of Maryland, Baltimore Antagonistes d'un canal cationique non sélectif dans des cellules neurales
CA2691199C (fr) 2007-06-22 2017-09-12 Marc J. Simard Inhibiteurs de canaux nc<sb>ca-atp</sb> pour therapie
BR112013018374A2 (pt) * 2011-01-25 2016-10-11 Monell Chemical Senses Centre composições e métodos para fornecer ou modular o sabor doce e métodos para rastrear os mesmos
GB201105659D0 (en) 2011-04-01 2011-05-18 Xention Ltd Compounds
CN108383759B (zh) * 2018-03-19 2021-01-26 江西师范大学 炔酰胺的胺氢化和膦氢化反应
CN113831259B (zh) * 2021-11-05 2023-07-25 内蒙古工业大学 一种芳香族偶氮化合物的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1185180B (de) 1963-10-19 1965-01-14 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1493672C3 (de) 1964-08-01 1974-05-02 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1518874C3 (de) 1964-10-07 1975-03-13 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE1518816C3 (de) 1965-03-24 1975-05-22 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
US4066639A (en) 1965-05-06 1978-01-03 Hoechst Aktiengesellschaft Benzene-sulfonyl semicarbazides and process for preparing them
DE59401361D1 (de) 1993-02-23 1997-02-06 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
DE4341655A1 (de) 1993-12-07 1995-06-08 Hoechst Ag Aminosubstituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
DE19505397A1 (de) 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832009A1 (de) 1998-07-16 2000-01-20 Hoechst Marion Roussel De Gmbh 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate
TR200100692T2 (tr) * 1998-09-10 2001-07-23 Aventis Pharma Deutschland Gmbh Otonom sinir sisteminin disfonksiyonlarının önlenmesinde Benzensulfonil (Tiyo) ürelerin kullanımı
DE19923086A1 (de) 1999-05-20 2000-11-23 Aventis Pharma Gmbh Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
EP1345892B1 (fr) 2005-03-09
DE60109324T2 (de) 2006-04-13
CA2427429C (fr) 2010-07-06
IL155657A (en) 2010-12-30
ATE290525T1 (de) 2005-03-15
JP4039625B2 (ja) 2008-01-30
US6511989B2 (en) 2003-01-28
AU1825302A (en) 2002-05-15
WO2002036556A3 (fr) 2002-07-04
MXPA03003608A (es) 2003-06-19
JP2004513109A (ja) 2004-04-30
DE60109324D1 (de) 2005-04-14
US20020123494A1 (en) 2002-09-05
AU2002218253B2 (en) 2006-07-06
PT1345892E (pt) 2005-06-30
WO2002036556A2 (fr) 2002-05-10
CA2427429A1 (fr) 2002-05-10
ES2237614T3 (es) 2005-08-01
EP1345892A2 (fr) 2003-09-24
DE10054481A1 (de) 2002-05-08

Similar Documents

Publication Publication Date Title
AU1825302A (en) Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
EP1148053A4 (fr) Derives 2h-phthalazine-1-one et medicaments renfermant ces derives comme principe actif
NO20072784L (no) Pyridenkarboksamidderivater for anvendelse som anticancer midler
CA2468649A1 (fr) Antagonistes du recepteur a2a d&#39;adenosine
BG104727A (en) Pharmaceutical composition of topiramate
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
WO2003048164A3 (fr) Antagonistes du recepteur a2a de l&#39;adenosine
WO1992019211A3 (fr) Imidazobenzoquinones et composition contenant ces dernieres permettant de prevenir ou de traiter l&#39;hypertension ou l&#39;insuffisance cardiaque
CA2220533A1 (fr) 3-amidochromanylsulfonyl(thio)urees, procedes pour leur preparation, leur utilisation et preparations pharmaceutiques contenant ces composes
DK1124841T3 (da) Substituerede phenylalkenoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler eller diagnosemidler og lægemidler, som indeholder dem
WO2003024457A1 (fr) Composition medicinale pour la prevention ou le traitement des troubles vasculaires cerebraux et de la cardiopathie
AU2363102A (en) Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
WO2000003978A3 (fr) Benzolsulfonyl-urees et -thiourees substituees en 2,5, leur procede de production, leur utilisation et les preparations pharmaceutiques les contenant
MX2009012644A (es) Derivados de di(hetero)arilciclohexano, su preparacion, su uso y composiciones farmaceuticas que los comprenden.
WO2001085709A3 (fr) Nouveaux composes presentant une activite anticancereuse et compositions pharmaceutiques les contenant
IL183807A0 (en) Piperidinesulfonylureas and-thioureas, their preparation, their use and pharmaceutical compositions comprising them
WO2001007418A3 (fr) Analogues de ceramide, leur procede de preparation et leur utilisation comme agents antitumoraux
YU81701A (sh) Cinamoilaminoalkil-supstituisani derivati benzensulfonamida
ES469020A1 (es) Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos
MY115229A (en) Substituted chromanylsulfonyl(thio) ureas, processes for their preparation their use in pharmaceutical preparations, and pharmaceutical preparations comprising them.
NZ527216A (en) Regulation of organic nitrate tolerance
UA27973C2 (uk) Лікарський засіб для лікування серцевої недостатності
WO2025188658A8 (fr) Modulateurs d&#39;akt1
WO2024211249A3 (fr) Modulateurs de trpml, leurs compositions et procédés d&#39;utilisation
MX9700781A (es) Diguanididas de acidos diarildicarboxilicos sustituidos, un procedimiento para su preparacion, su utilizacion como medicamento o agente diagnostico, asi como un medicamento que las contiene.